Download Free Sample Report

Molecular Diagnosis and Therapy Market, Global Outlook and Forecast 2023-2032

Molecular Diagnosis and Therapy Market, Global Outlook and Forecast 2023-2032

  • Published on : 28 September 2023
  • Pages :68
  • Report Code:SMR-7820552

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Molecular Diagnosis and Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnosis and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnosis and Therapy. This report contains market size and forecasts of Molecular Diagnosis and Therapy in global, including the following market information:

  • Global Molecular Diagnosis and Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
  • Global top five companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnosis and Therapy include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biom?rieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic and Illumina, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Diagnosis and Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnosis and Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, by Type, 2022 (%)

  • PCR
  • DNA Sequencing
  • NGS

Global Molecular Diagnosis and Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, by Application, 2022 (%)

  • Diagnostic Laboratories
  • Research & Academic Laboratories

Global Molecular Diagnosis and Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, By Region and Country, 2022 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Molecular Diagnosis and Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies Molecular Diagnosis and Therapy revenues share in global market, 2022 (%)

Key players include:

  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Biom?rieux Sa
  • Danaher Corporation
  • Diasorin
  • Grifols
  • Hologic
  • Illumina
  • Qiagen
  • Roche Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific

Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnosis and Therapy, market overview.
Chapter 2: Global Molecular Diagnosis and Therapy market size in revenue.
Chapter 3: Detailed analysis of Molecular Diagnosis and Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnosis and Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.